Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Ritlecitinib, brepocitinib superior to placebo for inducing remission in UC
Ritlecitinib and brepocitinib as induction therapies for ulcerative colitis (UC) appear to be more effective than placebo while having an acceptable short-term safety profile, according to the results of a phase IIb study.
Ritlecitinib, brepocitinib superior to placebo for inducing remission in UC
13 Jan 2023
Recent hyperglycaemia helps detect pancreatic cancer early
Pancreatic cancer may be identified early if assessment will be steered towards the point of recent hyperglycaemia based on elevated HbA1c, suggests a retrospective cohort study, noting that such early detection may then improve survival in cancer patients.
Recent hyperglycaemia helps detect pancreatic cancer early
11 Jan 2023
Meta-analysis: No link between PPI use and gastric cancer
Proton pump inhibitor (PPI) therapy does not appear to put individuals who require gastric acid suppression at increased risk of gastric cancer, according to a study.
Meta-analysis: No link between PPI use and gastric cancer
11 Jan 2023
Refractory Crohn’s disease responds well to risankizumab
In the treatment of patients with luminal Crohn’s disease and multiple prior drug failures, risankizumab induces clinical response in about three out of four patients and steroid-free clinical remission in about half, according to a study.